Sumitomo Mitsui Trust Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $237M | Buy |
|
|||||
|
2025
Q2 | $238M | Buy |
|
|||||
|
2025
Q1 | $308M | Buy |
|
|||||
|
2024
Q4 | $265M | Buy |
|
|||||
|
2024
Q3 | $241M | Buy |
|
|||||
|
2024
Q2 | $190M | Sell |
|
|||||
|
2024
Q1 | $275M | Sell |
|
|||||
|
2023
Q4 | $287M | Buy |
|
|||||
|
2023
Q3 | $315M | Sell |
|
|||||
|
2023
Q2 | $355M | Sell |
|
|||||
|
2023
Q1 | $440M | Sell |
|
|||||
|
2022
Q4 | $500M | Sell |
|
|||||
|
2022
Q3 | $503M | Sell |
|
|||||
|
2022
Q2 | $549M | Sell |
|
|||||
|
2022
Q1 | $540M | Buy |
|
|||||
|
2021
Q4 | $456M | Sell |
|
|||||
|
2021
Q3 | $441M | Sell |
|
|||||
|
2021
Q2 | $538M | Sell |
|
|||||
|
2021
Q1 | $553M | Buy |
|
|||||
|
2020
Q4 | $534M | Sell |
|
|||||
|
2020
Q3 | $585M | Sell |
|
|||||
|
2020
Q2 | $627M | Sell |
|
|||||
|
2020
Q1 | $652M | Buy |
|
|||||
|
2019
Q4 | $671M | Buy |
|
|||||
|
2019
Q3 | $375M | Buy |
|
|||||
|
2019
Q2 | $329M | Buy |
|
|||||
|
2019
Q1 | $342M | Buy |
|
|||||
|
2018
Q4 | $342M | Buy |
|
|||||
|
2018
Q3 | $330M | Buy |
|
|||||
|
2018
Q2 | $284M | Buy |
|
|||||
|
2018
Q1 | $304M | Buy |
|
|||||
|
2017
Q4 | $293M | Buy |
|
|||||
|
2017
Q3 | $297M | Sell |
|
|||||
|
2017
Q2 | $265M | Sell |
|
|||||
|
2017
Q1 | $266M | Buy |
|
|||||
|
2016
Q4 | $286M | Sell |
|
|||||
|
2016
Q3 | $268M | Sell |
|
|||||
|
2016
Q2 | $377M | Buy |
|
|||||
|
2016
Q1 | $325M | Buy |
|
|||||
|
2015
Q4 | $322M | Sell |
|
|||||
|
2015
Q3 | $291M | Buy |
|
|||||
|
2015
Q2 | $311M | Buy |
|
|||||
|
2015
Q1 | $278M | Buy |
|
|||||
|
2014
Q4 | $233M | Sell |
|
|||||
|
2014
Q3 | $203M | Sell |
|
|||||
|
2014
Q2 | $193M | Sell |
|
|||||
|
2014
Q1 | $220M | Sell |
|
|||||
|
2013
Q4 | $230M | Sell |
|
|||||
|
2013
Q3 | $206M | Sell |
|
|||||
|
2013
Q2 | $199M | Buy |
|